Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  49,473 results for ""Acarbose""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effectiveness of dual combination therapy of acarbose plus metformin and acarbose plus myo-inositol in ameliorating the metabolic and endocrinologic complications of polycystic ovary syndrome - A randomized controlled trial.

  • Authors : Andavar M; Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603 203, India.; Kamaraj R

Subjects: Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/drug therapy ; Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/complications ; Metformin*/Metformin*/Metformin*/therapeutic use

  • Source: European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2024 Sep; Vol. 300, pp. 6-11. Date of Electronic Publication: 2024 Jul 03.Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 0375672 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Commentary on 'Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose' by Jie Huang et al.

  • Authors : Zhang P; Division of Quantitative Methods & Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA.; Lee J

Subjects: Therapeutic Equivalency* ; Acarbose*/Acarbose*/Acarbose*/pharmacokinetics ; Acarbose*/Acarbose*/Acarbose*/administration & dosage

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Sep; Vol. 90 (9), pp. 2320-2322. Date of Electronic Publication: 2024 Jun 25.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Therapeutic potential of acarbose in ameliorating the metabolic and endocrinological complications of polycystic ovarian syndrome: a review.

  • Authors : Andavar M; SRM College of Pharmacy, Department of Pharmacy Practice, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, India.; Kamaraj R

Subjects: Acarbose*/Acarbose*/Acarbose*/therapeutic use ; Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/drug therapy ; Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/Polycystic Ovary Syndrome*/complications

  • Source: Current medical research and opinion [Curr Med Res Opin] 2024 Jul; Vol. 40 (7), pp. 1123-1135. Date of Electronic Publication: 2024 Jun 09.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A cocktail of rapamycin, acarbose, and phenylbutyrate prevents age-related cognitive decline in mice by targeting multiple aging pathways.

  • Authors : Jiang Z; Department of Comparative Medicine, School of Medicine, University of Washington, Seattle, WA, USA.; He Q

Subjects: Acarbose*/Acarbose*/Acarbose*/pharmacology ; Cognitive Dysfunction*/Cognitive Dysfunction*/Cognitive Dysfunction*/prevention & control ; Cognitive Dysfunction*/Cognitive Dysfunction*/Cognitive Dysfunction*/drug therapy

  • Source: GeroScience [Geroscience] 2024 Oct; Vol. 46 (5), pp. 4855-4868. Date of Electronic Publication: 2024 May 16.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Canagliflozin or acarbose versus placebo to ameliorate post-bariatric hypoglycaemia - The HypoBar I randomized clinical trial protocol.

  • Authors : Lobato CB; Department of Medicine, Copenhagen University Hospital, Amager and Hvidovre, Section of Endocrinology, Hvidovre, Denmark.; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Subjects: Acarbose*/Acarbose*/Acarbose*/therapeutic use ; Canagliflozin*/Canagliflozin*/Canagliflozin*/therapeutic use ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/prevention & control

  • Source: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2024 Jun; Vol. 41 (6), pp. e15320. Date of Electronic Publication: 2024 Mar 29.Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Studies on α-amylase inhibition by acarbose and quercetin using fluorescence, circular dichroism, docking, and dynamics simulations.

  • Authors : Kumar A; School of Biotechnology, Institute of Science, Banaras Hindu University, Varanasi 221005, India.; Kumar Singh V

Subjects: Acarbose*/Acarbose*/Acarbose*/pharmacology ; Acarbose*/Acarbose*/Acarbose*/chemistry ; Quercetin*/Quercetin*/Quercetin*/metabolism

  • Source: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2024 Jun 05; Vol. 314, pp. 124160. Date of Electronic Publication: Publisher: Elsevier Country of Publication: England NLM ID: 9602533 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3557

Record details

Read More Add to Saved list
×
Academic Journal

Mitigating candidiasis with acarbose by targeting Candida albicans α-glucosidase: in-silico, in-vitro and transcriptomic approaches.

  • Authors : David H; Quorum Sensing Laboratory, Centre for Research in Infectious Diseases (CRID), School of Chemical and Biotechnology, SASTRA Deemed to be University, Thanjavur, 613401, India.; Vasudevan S

Subjects: Candida albicans*/Candida albicans*/Candida albicans*/drug effects ; Candida albicans*/Candida albicans*/Candida albicans*/pathogenicity ; Acarbose*/Acarbose*/Acarbose*/pharmacology

  • Source: Scientific reports [Sci Rep] 2024 May 24; Vol. 14 (1), pp. 11890. Date of Electronic Publication: 2024 May 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of Acarbose Bioequivalence in Healthy Chinese Populations Using Novel Pharmacodynamic End Points.

  • Authors : Que L; Drug Clinical Trial Institution, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, China.; Qian Z

Subjects: Acarbose* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Humans

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Mar; Vol. 13 (3), pp. 233-239. Date of Electronic Publication: 2024 Jan 10.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Acarbose Mitigates Age-Dependent Alterations in Erythrocyte Membrane Transporters During Aging in Rats.

  • Authors : Arya JK; Department of Biochemistry, University of Allahabad, Allahabad, India.; Kumar R

Subjects: Acarbose*/Acarbose*/Acarbose*/pharmacology ; Glycoside Hydrolase Inhibitors*/Glycoside Hydrolase Inhibitors*/Glycoside Hydrolase Inhibitors*/pharmacology ; Erythrocyte Membrane*/Erythrocyte Membrane*/Erythrocyte Membrane*/chemistry

  • Source: Rejuvenation research [Rejuvenation Res] 2023 Aug; Vol. 26 (4), pp. 139-146. Date of Electronic Publication: 2023 Jun 12.Publisher: Mary Ann Liebert Inc Country of Publication: United States NLM ID: 101213381 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Design, synthesis, α-amylase and glucose diffusion inhibition, and molecular docking studies of new indenopyrazolones bearing benzothiazole derivatives.

  • Authors : Punia R; Department of Chemistry, Guru Jambheshwar University of Science and Technology, Hisar, Haryana 125001, India.; Mor S

Subjects: Acarbose* ; Glucose*; Structure-Activity Relationship

  • Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2024 May 01; Vol. 103, pp. 129692. Date of Electronic Publication: 2024 Mar 05.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  49,473 results for ""Acarbose""